Skip to main content

stock

TELO · Telomir Pharmaceuticals, Inc.

What Telomir Pharmaceuticals, Inc. reports to the SEC, read from its filings.

Open in the app

Price

The live TELO price and today's change.

Sign in to see this

Chart

Thirty days of daily bars, with signal levels drawn on them.

Sign in to see this

Signals

The latest signal group Nakagai's scanner recorded on TELO.

Sign in to see this

Options positioning

Gamma exposure levels from the options market.

Sign in to see this

Technicals

Trend, momentum and volatility gauges per timeframe.

Sign in to see this

What it is

Industry
Pharmaceutical Preparations (SIC 2834)
Filer (SEC EDGAR)
EDGAR filing index
Shares outstanding
68,774,956 as of 2026-08-12 (XBRL frame CY2026Q2I)

Key stats

Valuation

P/E
Locked
P/S
Locked
P/B
Locked
Enterprise value
Locked
EV/EBIT
Locked
FCF yield
Locked

Margins

Gross
—
Operating
—
Net
—

Returns

ROE
-116.7%
ROA
-109.5%

Health

Current ratio
16.1x
Debt/equity
—

Deep value

NCAV
$5.03M
NCAV per share
$0.07
Price/NCAV
Locked
NNWC
—
NNWC per share
—
Price/NNWC
Locked

Valuation and the price multiples are built on the live price. Trailing twelve months to 2026-06-30; balance sheet at 2026-06-30.

Sign in to see this

Debt is long-term debt and its current portion. Commercial paper and short-term borrowings are not counted.

Results

Period endRevenue (not reported by this company)Gross profit (not reported by this company)Operating incomeNet incomeFiling
2026-06-30—Revenue: unreported by this company.—Gross profit: unreported by this company.—-$1.72M
10-Q filed 2026-08-13
2026-03-31—Revenue: unreported by this company.—Gross profit: unreported by this company.—-$990,947
10-Q filed 2026-08-13
2025-12-31—Revenue: unreported by this company.—Gross profit: unreported by this company.—-$2.06M
10-K filed 2026-03-17
Derived: the full year minus the first three quarters, not a figure this filer reported as a quarter.
2025-09-30—Revenue: unreported by this company.—Gross profit: unreported by this company.—-$1.10M
10-Q filed 2025-11-10
2025-06-30—Revenue: unreported by this company.—Gross profit: unreported by this company.—-$5.07M
10-Q filed 2026-08-13
2025-03-31—Revenue: unreported by this company.—Gross profit: unreported by this company.$2.19M-$2.18M
10-Q filed 2026-05-14
Assembled from more than one filing; the filing above is only the newest of them.
2024-12-31—Revenue: unreported by this company.—Gross profit: unreported by this company.—-$2.90M
10-K filed 2026-03-17
Derived: the full year minus the first three quarters, not a figure this filer reported as a quarter.
2024-09-30—Revenue: unreported by this company.—Gross profit: unreported by this company.—-$5.99M
10-Q filed 2025-11-10
Assets
$5.37M
Equity
$5.03M

Balance as of 2026-06-30.

Ten years

Fiscal year endRevenueOperating incomeNet incomeFree cash flow
2025-12-31——-$10.41M—
2024-12-31——-$16.53M—
2023-12-31——-$13.07M—
2022-12-31——-$854,147—

Company filings

events

  • Material agreement, Unregistered share sale, Regulation FD disclosure

    Material agreementUnregistered share saleRegulation FD disclosure
    Oct 68-K
  • Regulation FD disclosure

    Regulation FD disclosure
    Sep 178-K
  • Shareholder vote results

    Shareholder vote results
    Sep 168-K
  • Regulation FD disclosure

    Regulation FD disclosure
    Sep 148-K
  • Regulation FD disclosure

    Regulation FD disclosure
    Aug 108-K
  • Regulation FD disclosure

    Regulation FD disclosure
    Jun 158-K

5% owners ()

  • John Paul DeJoria, as trustee of the John Paul DeJoria Family Trust, and in his individual capacity

    Stake update

    5.2%Aug 14SCHEDULE 13G/A
  • John Paul DeJoria, as trustee of the John Paul DeJoria Family Trust, and in his individual capacity

    Stake update

    9.4%Feb 12SCHEDULE 13G/A

Insiders, politicians and funds

Insider trades, last 90 days

No insider buys or sales filed in the last 90 days.

Politician trades, last 90 days

No politician trades filed in the last 90 days.

Funds

None of the tracked funds held this at their last 13F.

News

Stories that named TELO, and the market events around them.

Sign in to see this

Board

Recent signals

Signals open up here once a member has posted about TELO.

Signals are informational.

Posts · 0

No posts yet.

Be the first to say something about TELO.

nakagai

Signals on TELO come from a rule, not a model.

Nakagai’s scanner records a signal the moment a strategy’s rule matches on the bars. Members read those signals on their own desk, where an agent journals the tape and briefs them in plain English.

Members post on the TELO board

This page is not financial advice. Trade at your own judgment and risk. Read the terms that govern posting here.

Telomir Pharmaceuticals, Inc. (TELO): SEC filings, financials and insider trades · Nakagai